CCL18: A urinary marker of Gaucher cell burden in Gaucher patients

Journal of Inherited Metabolic Disease

Volumn 29, Issue 4, 2006, Pages 564-571

  Boot, Rolf G ^a   Verhoek, Marri ^a   Langeveld, Mirjam ^a   Renkema, G Herma ^b   Hollak, Carla E M ^a   Weening, Jan J ^a   Donker Koopman, Wilma E ^a   Groener, Johanna E ^a   Aerts, Johannes M F G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGLUCERASE; BIOLOGICAL MARKER; CHEMOKINE; CHEMOKINE CCL18; CHITOTRIOSIDASE; CREATININE; IMIGLUCERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY BURDEN; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMURIA; FEMALE; GAUCHER DISEASE; HUMAN; MALE; PATHOPHYSIOLOGY; PLASMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES, CC; FEMALE; GAUCHER DISEASE; GENOTYPE; HEXOSAMINIDASES; HUMANS; KIDNEY; MALE; MIDDLE AGED; TIME FACTORS;

EID: 33746875515     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-006-0318-8     Document Type: Article

References (20)

1. Aerts JM, Donker-Koopman WE, Koot M, et al (1986) Comparison of the properties of a soluble form of glucocerebrosidase from human urine with those of the membrane-associated tissue enzyme. Biochim Biophys Acta 863: 63-70.
2. Aerts JM, Hollak C, Boot R, et al (2003) Biochemistry of glycosphingolipids storage disorders: Implications for therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 358: 905-914.
3. Aguilera B, Ghauharali-Van Der Vlugt K, Helmond MT, et al (2003) Transglycosidase activity of chitotriosidase: Improved enzymatic assay for the human macrophage chitinase. J Biol Chem 278: 40911-40916.
4. Baldellou A, Andria G, Campbell PE, et al (2004) Paediatric non-neuronopathic Gaucher disease: Recommendations for treatment and monitoring. Eur J Pediatr 163: 67-75.
5. Barton NW, Brady RO, Dambrosia JM, et al (1991) Replacement therapy for inherited enzyme deficiency: Macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 324: 1464-1470.
6. Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3635-3668.
7. Boot RG, Renkema GH, Strijland A, et al (1995) Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 270: 26252-26256.
8. Boot RG, Renkema GH, Verhoek M, et al (1998) The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 273: 25680-25685.
9. Boot RG, Blommaart EF, Swart E, et al (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 276: 6770-6778.
10. Boot RG, Verhoek M, De Fost M, et al (2004) Marked elevation of the chemokine CCL18/PARC in Gaucher disease: A novel surrogate marker for assessing therapeutic intervention. Blood 103: 33-39.
11. Boven LA, van Meurs M, Boot RG, et al (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 122: 359-369.
12. Cox TM (2003) Future perspectives for glycolipid research in medicine. Philos Trans R Soc Lond B Biol Sci 358: 967-973.
13. Cox T, Lachmann R, Hollak C, et al (2000) Novel oral treatment of Gaucher's disease with N -butyldeoxynojirimycin (OGT918) to decrease substrate biosynthesis. Lancet 355: 1481-1485.
14. Cox TM, Aerts JM, Andria G, et al (2003) The role of the iminosugar N -butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement. J Inherit Metab Dis 26: 513-526.
15. Deegan PB, Moran MT, McFarlane I, et al (2005) Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis 35: 259-267.
16. Hollak CEM, van Weely S, van Oers MHJ, et al (1994) Elevated plasma chitotriosidase: A novel biochemical hallmark of Gaucher disease. J Clin Invest 93: 1288-1292.
17. Hollak CE, Maas M, Aerts JM (2001) Clinically relevant therapeutic endpoints in type I Gaucher disease. J Inherit Metab Dis 24 (Supplement 2): 97-105.
18. Moran MT, Schofield JP, Hayman AR, et al (2000) Pathologic gene expression in Gaucher disease: Up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood 96: 1969-1978.
19. Platt FM, Jeyakumar M, Andersson U, et al (2001) Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J Inherit Metab Dis 24: 275-290.
20. Slot C (1965) Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17: 381-387.